Introduction {#sec0005}
============

Gonorrhea is one of the more common sexually transmitted infections worldwide and in the United States, with the potential to spread via mucous membranes including the genitourinary tract, oropharynx, rectum, as well as the conjunctivae. In the United States in 2017, the incidence of infections with *Neisseria gonorrhoeae* was 171.9 cases per 100,000, with an infection rate that has increased by 75.2 % since a low point in 2009. In comparison, in 2017 primary syphilis and chlamydia were noted at an infection rate of 12.1 cases per 100,000, and 528.8 cases per 100,000, respectively \[[@bib0005]\]. Moreover, in addition to the recently growing gonococcal infection rates, reduced antimicrobial susceptibility has been increasingly noted as well \[[@bib0010]\]. Disseminated gonococcal infection (DGI) occurs in 0.5--3 % of patients with gonorrhea and may present as septic arthritis \[[@bib0015]\].While other pathogens implicated in septic arthritis are known to frequently cause osteomyelitis, there are few reports of osteomyelitis secondary to gonococcal arthritis with little guidance existing for appropriate treatment courses for this condition \[[@bib0010]\]. We describe a case of gonococcal septic arthritis complicated by osteomyelitis of the humeral head in a teenage female with DGI requiring prolonged antimicrobial treatment, and review previous DGI cases with osteomyelitis reported in the literature.

Case report {#sec0010}
===========

A healthy 14-year-old girl presented to our hospital with a 5-day history of worsening right shoulder pain and fever. She initially had left hip, thigh, and great toe pain with difficulty bearing weight on that leg but this resolved after one day. She presented 3 days later with worsening of her shoulder pain and decreased range of motion. She denied any trauma, or recent illness. Furthermore, international travel, exposure to animals, outdoor activity in wooded areas including tick bites, or any history of sexual activity were denied. Confronted with the diagnosis of a gonococcal infection, the patient later revealed unprotected sexual intercourse with a new male partner approximately two weeks prior to presentation. In her review of systems, no dysuria, vaginal discharge, throat pain, numbness of right arm, rashes, respiratory symptoms, redness over joint, or joint swelling were noted. Physical exam revealed an afebrile patient with stable vital signs who was in moderate distress due to pain in her right shoulder while holding her right arm to her chest. The skin over the right shoulder was intact with no obvious deformity, erythema or signs of effusion. Tenderness to palpation was noted at both anterior and posterior aspects of the shoulder joint. The active range of motion could not be accurately determined due to pain but the right shoulder could be passively flexed to 30 degrees and abducted to 25 degrees. The sensation in the right arm was intact with good capillary refill. Findings of the remainder of the physical examination were unremarkable. A radiograph of the right shoulder showed no abnormalities.

Laboratory studies revealed a white blood cell count of 9300/μL, an elevated C-reactive protein (CRP) of 152 mg/dL, and an abnormal erythrocyte sedimentation rate (ESR) of 102 mm/h. Her urinalysis was notable for leukocyte esterase with \>50 white blood cell per high powered field, and a subsequent urine sample detected *N. gonorrhoeae* by nucleic acid amplification test (NAAT) methodology. Arthrocentesis resulted in drainage of 7 ml of cloudy yellow fluid with 63,655 cells/ml with 91 % segmented neutrophils in the differential cell count. The Gram stain did not show any organisms.

The affected joint was incised and drained with placement of a Penrose drain, and empiric antimicrobial treatment with intravenous (IV) ceftriaxone (75 mg/kg/day) and IV clindamycin (30 mg/kg/day) was started. The synovial fluid culture then yielded growth of *N. gonorrhoeae* with susceptibility to ceftriaxone (MIC \< 0.1 μg/mL) which allowed continuation of the antimicrobial treatment with IV ceftriaxone alone. After 1 week of treatment, pain and mobility of the affected shoulder had not improved, and magnetic resonance imaging (MRI) demonstrated a focus of osteomyelitis in the right humeral head ([Fig. 1](#fig0005){ref-type="fig"}, [Fig. 2](#fig0010){ref-type="fig"}). At this time treatment was transitioned to oral cefixime 400 mg daily, which was continued for a total of 35 days until inflammatory markers (CRP and ESR) had normalized although joint functional recovery was incomplete (i.e. not able to raise hand above head) at 6 week follow up post-hospitalization. Patient was lost to follow up after this visit.Fig. 1T2 MRI image of right shoulder on day 6 of ceftriaxone treatment with evidence of septic arthritis and persistent joint effusion with diffuse synovial thickening, as well as a focal lesion (1.8 × 0.7 cm) on the proximal humeral epiphysis consistent with acute osteomyelitis.Fig. 1Fig. 2T1 MRI image at same time period as [Fig. 2](#fig0010){ref-type="fig"} with similar findings of arthritis and osteomyelitis.Fig. 2

A literature search was conducted using PubMed with the search terms "Gonococcal Osteomyelitis" and "Gonorrhoeae Osteomyelitis". References within articles were reviewed for additional cases. In total, we identified 18 previous cases of DGI-associated osteomyelitis in the English literature between 1968 and 2020 ([Table 1](#tbl0005){ref-type="table"}).Table 1Cases of gonococcal osteomyelitis reported in the peer-reviewed literature since 1968.Table 1Author (year published)AgeSexJoint/bone involvedTreatmentOutcomeKeiser et al (1968) \[[@bib0085]\]20FFirst MCPIV PCN 5 days, oral PCN 10 daysComplete resolutionMagee (1975) \[[@bib0090]\]14FFirst PIPIV PCN (unknown duration)Complete resolutionAngevine et al (1976) \[[@bib0095]\]16FSecond MCPIV penicillin 3 weeks, oral PCN 3 weeksResidual limitation -crepitance, decreased flexion, joint space narrowingGantz et al (1976) \[[@bib0100]\]31FSecond MCPIV PCN 1 week, oral ampicillin 3 weeksComplete resolutionMehta and Wright (1977) \[[@bib0105]\]20FHipIV PCN 6 days, oral ampicillin 2 weeksResidual limitation -- limited ROM and degenerative OA changes on imagingLiftik et al (1978) \[[@bib0110]\]25MMTP, MCPIV PCN 4 days, oral ampicillin 1 week, oral tetracycline 2 weeksComplete resolutionRinaldi et al (1982) \[[@bib0115]\]22FLeft wristIV cefoxitin 3 weeks, Open drainage, Oral tetracycline 10daysResidual limitation - lysis and cortical erosion at the inferior radioulnar jointsTindall and Regan-Smith (1983) \[[@bib0120]\]29MHip, shoulderIV PCN 1 month, oral PCN 2 weeksPermanent disability, hip replacementBlack and Cohen (1984) \[[@bib0030]\]46FFirst MTOral cephalexin 1 week, Oral PCN for 5 weeksResidual limitation -limited ROMHurley et al (1987) \[[@bib0125]\]27FWristIV and oral antibiotics for more than 6 weeksResidual limitation -- limited ROMIngram et al (1991) \[[@bib0065]\]24MCuneiform bone, third MTPOral cephalexin 7 days, Surgical debridement, IV CTX 6 weeksComplete resolutionDuvauchelle and Pien (1994) \[[@bib0130]\]24MLeft footIV antibiotics alone 6 weeksComplete resolutionShibata et al (2004)^a^ \[[@bib0050]\]20FShoulder, MTP, MCPOral faropenem and clarithromycin 4 days, IV cephazolin 4 days, oral minocycline 4 days, bone graft, IV minocycline 6 days, oral for 7 daysBone erosion of the humeral and scapular necksvan der Zwan et al (2005) \[[@bib0045]\]41MRight humerusIV amoxicillin for 1 week followed by 7 weeks oral amoxicillinComplete resolutionRehnstrom et al (2016) \[[@bib0015]\]61MLeft kneeMultiple treatments due to misdiagnosis, eventually IV CTX for 9 days followed by 12 months oral cefiximeProsthesis operationRehnstrom et al (2016) \[[@bib0015]\]65MLeft 3rd MCPMultiple treatments due to delayed diagnosis, eventually 4 months oral cefiximeResidual limitation -impaired affected jointGharamti et al (2019) \[[@bib0055]\]37MRight 5th metatarsalIV ceftriaxone for 1 weekComplete resolutionRoy et al (2020) \[[@bib0060]\]55ML3-L4 vertebraeIV ceftriaxone for 8 weeksIncomplete resolution at 8 weeks post treatmentPresented case (2020)14FRight humeral headIV ceftriaxone for 9days, oral cefixime for 35 daysResidual limitation -- limited range of motion[^1][^2]

Discussion {#sec0015}
==========

DGI results from systemic spread of *N. gonorrhoeae* that has usually been sexually transmitted. DGI can occur at any age, although most are younger than 40 years of age. Historically, DGI has higher incidence in females than males, possibly with some relationship to physiologic changes associated with menstruation and pregnancy, but that trend has now reversed and infection is more common in males \[[@bib0005],[@bib0020]\]. Prior symptomatic genitourinary infection is uncommonly found in patients with DGI, and the major risk factor for disseminated infection is thought to be asymptomatic mucosal infection that delays diagnosis and treatment \[[@bib0025]\]. It encompasses a wide spectrum of clinical manifestations, with the classic triad of rash, arthritis, and tenosynovitis predominating. These disseminated infections are a leading cause of acute septic arthritis in adults, as well as rarely causing endocarditis, hepatitis, or meningitis. Gonococcal osteomyelitis is also a rare manifestation of disseminated infection with *N. gonorrhoeae*, typically appearing in those patients with untreated septic arthritis for an extended period of time. In the pre-antibiotic era, DGI commonly resulted in septic arthritis and up to 85 % of patients with gonococcal infection developed radiographic features consistent with adjacent osteomyelitis \[[@bib0030]\]. Effective antimicrobial treatment of infections with *N. gonorrhoeae* have resulted in DGI becoming more of a rare occurrence, although increasing rates of antibiotic resistance have recently been noted \[[@bib0010],[@bib0035]\].

The mechanism of gonococcal bone infection could be either by hematogenous spread of *N. gonorrhoeae* during early gonococcal bacteremia or by direct inoculation from the surrounding infected joint. In the presented case, we favored direct inoculation over hematogenous spread as the likely mechanism as the osteomyelitic focus was located in the epiphysis, surrounded and in direct contact with the septic joint capsule, and not in the metaphysis where most osteomyelitis following hematogenous spread occurs because of slower-flowing vasculature \[[@bib0040]\]. Further, delay of detection and treatment for DGI seem to increase the risk for developing gonococcal osteomyelitis and hence support the notion that not early bacteremia of *N. gonorrhoeae* but prolonged exposure of bone to an infected joint may result in osteomyelitis as has been described for other reported cases of gonococcal osteomyelitis, especially of the long bones \[[@bib0045],[@bib0050]\]. One review of nine patients with gonococcal osteomyelitis demonstrated that symptoms of arthralgia may begin insidiously, different from the presentation of other common osteomyelitis pathogens that may present more acutely. Furthermore, it was noted that significant delay between the onset of joint symptoms and the initiation of appropriate antibiotic therapy was a common risk factor among patients found to have confirmed gonococcal osteomyelitis \[[@bib0030]\]. Our patient was symptomatic for about one week with shoulder pain, poly-arthralgia symptoms, and fever before reporting to our institution, which may have been early manifestations of disseminated gonococcal infection that went unrecognized. Although surgical drainage was completed early in the hospital course and antibiotic treatment was started promptly due to suspicion of septic arthritis, our patient's delay from onset of symptoms to seeking treatment may have been a factor in her progression to osteomyelitis.

Including the current case, we were able to review a total of 19 cases of gonococcal osteomyelitis that have been reported in the literature during the antibiotic era ([Table 1](#tbl0005){ref-type="table"}) \[[@bib0015],[@bib0045], [@bib0050], [@bib0055]\]. Reviewed patients had a median age (range) of 25 years (14--65) with 10 female patients and 9 male patients. This is slightly different from overall gonorrhea infection statistics, which are skewed towards males \[[@bib0005]\]. The most common location of gonococcal osteomyelitis in reported cases was the joints of the hand and wrist (40 %) followed by the joints of the foot (20 %) and shoulder joint (20 %). Two patients had an affected hip (10 %) and one had an affected knee (5 %). Some patients had multiple joints affected, which can occur but is relatively rare \[[@bib0030]\]. One case occurred in the L3-L4 vertebrae with associated discitis \[[@bib0060]\]. Comorbidities were only rarely reported, however one case was HIV-1 infected \[[@bib0065]\].

Given the rare occurrence of osteomyelitis associated with DGI, its antimicrobial treatment (antibiotic agents and duration of the treatment) is not well defined \[[@bib0035],[@bib0070],[@bib0075]\]. Third-generation cephalosporins with variable duration of treatment have been mostly used. Infections in smaller bones like metatarsals were successfully treated by using parenteral ceftriaxone for one week, while infections affecting long bones appeared to need longer courses in the range of 4--6 weeks of parenteral ceftriaxone \[[@bib0015],[@bib0045],[@bib0055],[@bib0060]\]. In one case a patient with confirmed gonococcal osteomyelitis of the knee required 12 months of treatment with oral cefixime resulting in incomplete resolution \[[@bib0015]\].Of the five long-bone and vertebral cases for which data on treatment length was available, the average parenteral antibiotic treatment duration was 21.5 days, followed by an average oral antibiotic treatment duration of 26.3 days. Due to the increasing rates of antibiotic resistance seen with gonococcal infections, the CDC currently recommends ceftriaxone and azithromycin as first line agents for treating DGI until susceptibility results become available \[[@bib0005],[@bib0010]\].Emerging resistance will continue to limit treatment options and raises the risk for progression of DGI to osteomyelitis due to delay in effective treatment \[[@bib0080]\].

Of note, more than half of reported cases (11/19, 58 %) were affected by some form of residual limitation at last follow up visit, ranging from diminished range of motion to permanent sequelae, including bony erosions and need for prosthesis ([Table 1](#tbl0005){ref-type="table"}). The presented case also had residual limitations in the form of marginally restricted range of motion at the time of last follow up 6 weeks after finishing treatment.

In conclusion, at a time of increasing incidence of *N. gonorrhoeae* infection as well as increasing antimicrobial resistance clinicians should maintain a high index of suspicion for DGI with potential progression from gonococcal septic arthritis to adjacent osteomyelitis, especially in those patients with slowly resolving symptoms. To assure full recovery, early treatment along with a prolonged antibiotic treatment course and careful follow-up evaluations of clinical symptoms resolution may be needed.
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[^1]: Abbreviations: PCN=penicillin, IV=intravenous, CTX=ceftriaxone, ROM=range of motion, OA=osteoarthritis, MCP=metacarpophalangeal, MTP=metatarsophalangeal, MT=metatarsal, PIP -- proximal interphalangeal.

[^2]: a=selections from Shibata 2004 and prior are adapted from Shibata et al 2004 table \[[@bib0050]\].
